Programmed death ligand-1 (PD-L1) heterogeneity in non-small cell lung cancer (NSCLC)

被引：1
|
作者：
McLaughlin, Joseph [1 ]
Schalper, Kurt A. [2 ]
Carvajal-Hausdorf, Daniel E. [2 ]
Pelekanou, Vasiliki [2 ]
Velcheti, Vamsidhar [1 ]
Haack, Herbert [3 ]
Silver, Matthew R. [3 ]
Herbst, Roy [1 ]
LoRusso, Patricia [1 ]
Rimm, David L. [2 ]
机构：
[1] Smilow Canc Ctr, Dept Med Oncol, New Haven, CT USA
[2] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[3] Cell Signaling Technol, Danvers, MA USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-1310
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1310
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Circulating Programmed Death Ligand-1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
    Vecchiarelli, S.
    D'Incecco, A.
    Minuti, G.
    Gallo, M.
    De Luca, A.
    Landi, L.
    Bennati, C.
    Spreafico, M.
    D'Arcangelo, M.
    Attilia, L.
    Mazza, V.
    Normanno, N.
    Cappuzzo, F.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2389 - S2389
  • [2] Circulating programmed death ligand-1 (PD-L1) in non-small cell lung cancer (NSCLC)
    Vecchiarelli, S.
    D'Incecco, A.
    Gallo, M.
    De Luca, A.
    Minuti, G.
    Landi, L.
    Bennati, C.
    Spreafico, M.
    D'Arcangelo, M.
    Attilia, L.
    Mazza, V.
    Normanno, N.
    Cappuzzo, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] Programmed Death Ligand-1 (PD-L1) Expression in Operable Non-Small Cell Lung Cancer (NSCLC) by Immunohistochemical Analysis
    Babayeva, Sabina
    Dyatlov, Artem
    Pallavi, Ranjita
    Fanucchi, Michael
    Puccio, Carmelo
    Lafaro, Rocco
    Shakil, Fouzia
    Fallon, John T.
    Zhong, Minghao
    LABORATORY INVESTIGATION, 2016, 96 : 467A - 467A
  • [4] Programmed death ligand-1 (PD-L1) expression in non-small cell lung cancer (NSCLC), results of a single institution
    Slezak, A.
    Toth, E.
    VIRCHOWS ARCHIV, 2018, 473 : S112 - S112
  • [5] Programmed Death Ligand-1 (PD-L1) Expression in Operable Non-Small Cell Lung Cancer (NSCLC) by Immunohistochemical Analysis
    Babayeva, Sabina
    Dyatlov, Arteni
    Pallavi, Ranjita
    Fanucchi, Michael
    Puccio, Carmelo
    Lafaro, Rocco
    Shakil, Fouzia
    Fallon, John T.
    Zhong, Minghao
    MODERN PATHOLOGY, 2016, 29 : 467A - 467A
  • [6] Association Between Programmed Death Ligand-1 (PD-L1) Expression and Clinicopathological Features in Non-small Cell Lung Cancer (NSCLC)
    Valcarcel Gonzalez, S.
    Diaz, P.
    Villanueva Palicio, N.
    Alvarez Fernandez, C.
    Contreras Toledo, D. C.
    Mihic Gongora, L.
    Rodriguez Gonzalez, A.
    Velasco Durantez, V.
    Solis Hernandez, M. D. P.
    Esteban Gonzalez, E.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S569 - S570
  • [7] Programmed death-ligand (PD-L1) expression and tissue heterogeneity in advanced non-small cell lung cancer (NSCLC)
    Decatris, Marios
    Hayes, Mark
    Du Rand, Ingrid
    Ryan, Philip
    Phillips, Aled
    El-Batrawy, Sherouk
    Homewood, Renate
    Thomas, Joy
    Bowden, Caitlin
    Taniere, Phillipe
    LUNG CANCER, 2021, 156 : S29 - S30
  • [8] Programmed Death Ligand-1 (PD-L1) Expression in Patients with Non-Small Cell Lung Cancer (NSCLC) with Unusual Metastasis: A Case Series
    Tsugitomi, R.
    Nishimura, N.
    Imai, R.
    Okafuji, K.
    Kitamura, A.
    Tomishima, Y.
    Jinta, T.
    Suzuki, K.
    Tamura, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [9] Programmed Death Ligand 1 (PD-L1) Expression in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
    D'Arcangelo, M.
    Puccetti, M.
    Bravaccini, S.
    D'Incecco, A.
    Ligorio, C.
    Terracciano, L.
    Damiani, S.
    Ravaioli, S.
    Tumedei, M. M.
    Bennati, C.
    Minuti, G.
    Vecchiarelli, S.
    Landi, L.
    Incarbone, M.
    Milesi, M.
    Cappuzzo, F.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2390 - S2390
  • [10] The prevalence of programmed death ligand-1 (PD-L1) expression in non-small cell lung cancer in an unselected, consecutive population
    Skov, Birgit Guldhammer
    Rorvig, Sara Bird
    Jensen, Thomas Hartvig Lindkaer
    Skov, Torsten
    MODERN PATHOLOGY, 2020, 33 (01) : 109 - 117
12345